Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development

International Journal of Stroke : Official Journal of the International Stroke Society
Lutz HilbrichSalim Yusuf

Abstract

Research into the prevention and treatment of stroke and cardiovascular disease has focused primarily on the needs of high-income countries (HIC). However, the majority of all stroke and cardiovascular deaths occurs in low- and middle-income countries (LMIC), with further rises in these countries predicted. In HIC, proven strategies for the treatment of stroke and cardiovascular disease are well established and cost-effective. Developing strategies to include LMIC is therefore crucial to curb the global epidemic of stroke and cardiovascular disease. For example, pharmaceutical companies are being encouraged to make certain drugs more affordable in low- and middle-income companies, and the same principle could be applied to drugs for the prevention of stroke. Furthermore, centers from LMIC are now often included in clinical trials, resulting in trials that are more globally relevant and affordable and that enhance the participation of healthcare professionals from a broad range of countries. More cost-effective drug development processes and affordable prices, while protecting intellectual property rights, will prevent the ever-increasing burden of stroke becoming unmanageable in LMIC.

References

Dec 2, 1996·The Medical Journal of Australia·K L ZhangD Li
Mar 11, 1998·Circulation·K S Reddy, S Yusuf
Jun 24, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·R A JenkinsC Khamboonruang
Nov 11, 1998·Nature Medicine·A D Lopez, C C Murray
Nov 4, 1992·PharmacoEconomics·D Dunbabin
Feb 15, 2001·International Journal of Epidemiology·T TruelsenG Boysen
Nov 17, 2001·Asia Pacific Journal of Clinical Nutrition·G L Khor
Dec 12, 2001·Stroke; a Journal of Cerebral Circulation·D SmadjaUNKNOWN ERMANCIA Study Group
Jan 5, 2002·International Journal of Epidemiology·T TruelsenK Jamrozik
Feb 19, 2002·Journal of Contaminant Hydrology·Earl D MattsonEric R Lindgren
May 16, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·C K Kasper
May 25, 2002·Public Health Nutrition·H H Vorster
Jul 18, 2003·Lancet·Ke XuChristopher J L Murray
Jun 3, 2004·JAMA : the Journal of the American Medical Association·Derek YachKaren J Hofman
Jun 23, 2004·Lancet Neurology·Ruth BonitaFrank Yatsu
Dec 29, 2004·Lancet Neurology·Kjell Asplund
Feb 11, 2005·Clinical and Experimental Hypertension : CHE·Serap Erdine, Sinan Nazif Aran
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Peter A RinglebPeter D Schellinger
Sep 16, 2005·The New England Journal of Medicine·David Blumenthal, William Hsiao
Jan 4, 2006·American Journal of Preventive Medicine·Daniel LemogoumPascal Bovet
Feb 10, 2006·Journal of Hypertension·Carlene M M LawesAnthony Rodgers
Feb 10, 2006·Journal of Hypertension·Carlene M M LawesAnthony Rodgers
May 19, 2006·Journal of Thrombosis and Haemostasis : JTH·T D Szucs, M Bramkamp
Aug 10, 2006·JAMA : the Journal of the American Medical Association·Edward J MillsDavid R Bangsberg

❮ Previous
Next ❯

Software Mentioned

ONTARGET
INTERSTROKE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.